TRADES
Latest Trades
3736
results found
FUND
DATE
ACTION
TICKER
COMPANY
SHARES
% of ETF
ARKK 17 Mar 2023 Buy SQ BLOCK INC 50,858 0.0481
ARKK 17 Mar 2023 Buy CERS CERUS CORP 131,947 0.0049
ARKK 16 Mar 2023 Buy CERS CERUS CORP 9,764 0.0004
ARKK 15 Mar 2023 Sell TWLO TWILIO INC 400,266 0.3381
ARKK 15 Mar 2023 Buy SQ BLOCK INC 104,480 0.1022
ARKK 15 Mar 2023 Sell EXAS EXACT SCIENCES CORP 18,954 0.0163
ARKK 14 Mar 2023 Sell TWLO TWILIO INC 264,648 0.2444
ARKK 14 Mar 2023 Buy SQ BLOCK INC 159,654 0.1703
ARKK 14 Mar 2023 Sell EXAS EXACT SCIENCES CORP 762 0.0007
ARKK 14 Mar 2023 Buy CERS CERUS CORP 130,490 0.0054
ARKK 13 Mar 2023 Sell TWLO TWILIO INC 33,316 0.0318
ARKK 13 Mar 2023 Buy TSLA TESLA INC 15,349 0.0388
ARKK 13 Mar 2023 Buy SQ BLOCK INC 77,991 0.0812
ARKK 13 Mar 2023 Buy ROKU ROKU INC 83,844 0.0737
ARKK 13 Mar 2023 Sell EXAS EXACT SCIENCES CORP 239,931 0.2328
ARKK 13 Mar 2023 Buy CERS CERUS CORP 2,572 0.0001
ARKK 10 Mar 2023 Sell TWLO TWILIO INC 81,550 0.0780
ARKK 10 Mar 2023 Buy COIN COINBASE GLOBAL INC 103,129 0.0797
ARKK 10 Mar 2023 Buy CERS CERUS CORP 175,815 0.0069
ARKK 9 Mar 2023 Sell TWLO TWILIO INC 132,922 0.1252
ARKK 9 Mar 2023 Sell EXAS EXACT SCIENCES CORP 210,836 0.1877
ARKK 9 Mar 2023 Buy DNA GINKGO BIOWORKS HOLDINGS INC 1,675,013 0.0296
ARKK 9 Mar 2023 Buy COIN COINBASE GLOBAL INC 301,437 0.2383
ARKK 9 Mar 2023 Buy CERS CERUS CORP 327,323 0.0125
ARKK 8 Mar 2023 Buy TSLA TESLA INC 51,960 0.1280
ARKK 8 Mar 2023 Sell EXAS EXACT SCIENCES CORP 168,894 0.1521
ARKK 8 Mar 2023 Buy DNA GINKGO BIOWORKS HOLDINGS INC 1,141,280 0.0200
ARKK 8 Mar 2023 Buy CERS CERUS CORP 378,852 0.0144
ARKK 7 Mar 2023 Buy TWST TWIST BIOSCIENCE CORP 36,375 0.0089
ARKK 7 Mar 2023 Buy DNA GINKGO BIOWORKS HOLDINGS INC 3,879,133 0.0686
ARKK 7 Mar 2023 Buy COIN COINBASE GLOBAL INC 47,568 0.0393
ARKK 7 Mar 2023 Buy CERS CERUS CORP 386,861 0.0144
ARKK 6 Mar 2023 Sell MTLS MATERIALISE NV 122 0.0000
ARKK 6 Mar 2023 Sell EXAS EXACT SCIENCES CORP 56,865 0.0516
ARKK 6 Mar 2023 Buy DNA GINKGO BIOWORKS HOLDINGS INC 887,034 0.0156
ARKK 6 Mar 2023 Buy CERS CERUS CORP 466,778 0.0172
ARKK 3 Mar 2023 Buy NVTA INVITAE CORP 198,023 0.0047
ARKK 3 Mar 2023 Sell MTLS MATERIALISE NV 3,629 0.0004
ARKK 3 Mar 2023 Sell EXAS EXACT SCIENCES CORP 7,501 0.0065
ARKK 3 Mar 2023 Buy DNA GINKGO BIOWORKS HOLDINGS INC 1,978,774 0.0357
ARKK 3 Mar 2023 Buy COIN COINBASE GLOBAL INC 103,148 0.0862
ARKK 3 Mar 2023 Buy CERS CERUS CORP 57,119 0.0022
ARKK 2 Mar 2023 Sell TXG 10X GENOMICS INC 121,318 0.0761
ARKK 2 Mar 2023 Sell PD PAGERDUTY INC 198,345 0.0782
ARKK 2 Mar 2023 Buy NVTA INVITAE CORP 23,917 0.0005
ARKK 2 Mar 2023 Sell MTLS MATERIALISE NV 4,947 0.0006
ARKK 2 Mar 2023 Sell EXAS EXACT SCIENCES CORP 73,474 0.0619
ARKK 2 Mar 2023 Buy DNA GINKGO BIOWORKS HOLDINGS INC 1,835,780 0.0328
ARKK 2 Mar 2023 Sell DKNG DRAFTKINGS INC 340,178 0.0833
ARKK 2 Mar 2023 Buy COIN COINBASE GLOBAL INC 31,348 0.0255
ARKK 2 Mar 2023 Buy CERS CERUS CORP 126,687 0.0046
ARKK 1 Mar 2023 Sell TXG 10X GENOMICS INC 9,210 0.0058
ARKK 1 Mar 2023 Sell PD PAGERDUTY INC 19,395 0.0077
ARKK 1 Mar 2023 Buy NVTA INVITAE CORP 224,493 0.0049
ARKK 1 Mar 2023 Sell EXAS EXACT SCIENCES CORP 39,560 0.0328
ARKK 1 Mar 2023 Sell DKNG DRAFTKINGS INC 19,609 0.0049
ARKK 1 Mar 2023 Buy CERS CERUS CORP 286,367 0.0100
ARKK 28 Feb 2023 Sell MTLS MATERIALISE NV 460 0.0001
ARKK 27 Feb 2023 Sell MTLS MATERIALISE NV 1,103 0.0001
ARKK 24 Feb 2023 Buy U UNITY SOFTWARE INC 34,178 0.0141
ARKK 24 Feb 2023 Sell EXAS EXACT SCIENCES CORP 63,099 0.0517
ARKK 24 Feb 2023 Sell DKNG DRAFTKINGS INC 190,593 0.0471
ARKK 24 Feb 2023 Buy COIN COINBASE GLOBAL INC 128,396 0.1022
ARKK 23 Feb 2023 Buy U UNITY SOFTWARE INC 393,338 0.1667
ARKK 23 Feb 2023 Sell PD PAGERDUTY INC 46,476 0.0186
ARKK 23 Feb 2023 Sell EXAS EXACT SCIENCES CORP 127,317 0.1086
ARKK 23 Feb 2023 Buy COIN COINBASE GLOBAL INC 53,783 0.0459
ARKK 22 Feb 2023 Sell TXG 10X GENOMICS INC 72,892 0.0487
ARKK 22 Feb 2023 Sell PD PAGERDUTY INC 59,888 0.0244
ARKK 22 Feb 2023 Sell EXAS EXACT SCIENCES CORP 52,703 0.0468
ARKK 22 Feb 2023 Sell DKNG DRAFTKINGS INC 178,593 0.0481
ARKK 22 Feb 2023 Buy COIN COINBASE GLOBAL INC 181,972 0.1478
ARKK 21 Feb 2023 Sell ROKU ROKU INC 10,393 0.0091
ARKK 17 Feb 2023 Buy SHOP SHOPIFY INC 102,825 0.0568
ARKK 17 Feb 2023 Sell ROKU ROKU INC 90,287 0.0815
ARKK 17 Feb 2023 Sell EXAS EXACT SCIENCES CORP 187,880 0.1483
ARKK 16 Feb 2023 Buy SHOP SHOPIFY INC 609,763 0.3373
ARKK 16 Feb 2023 Sell ROKU ROKU INC 95,930 0.0857
ARKK 16 Feb 2023 Sell EXAS EXACT SCIENCES CORP 66,356 0.0524
ARKK 15 Feb 2023 Sell MTLS MATERIALISE NV 3,219 0.0004
ARKK 14 Feb 2023 Sell EXAS EXACT SCIENCES CORP 17,862 0.0157
ARKK 14 Feb 2023 Buy COIN COINBASE GLOBAL INC 11,778 0.0089
ARKK 13 Feb 2023 Sell MTLS MATERIALISE NV 3,136 0.0004
ARKK 13 Feb 2023 Sell EXAS EXACT SCIENCES CORP 111,326 0.0980
ARKK 13 Feb 2023 Buy COIN COINBASE GLOBAL INC 102,281 0.0771
ARKK 10 Feb 2023 Sell EXAS EXACT SCIENCES CORP 85,824 0.0726
ARKK 10 Feb 2023 Buy COIN COINBASE GLOBAL INC 139,105 0.1068
ARKK 8 Feb 2023 Sell MTLS MATERIALISE NV 459 0.0001
ARKK 7 Feb 2023 Buy RBLX ROBLOX CORP 50,134 0.0237
ARKK 7 Feb 2023 Sell MTLS MATERIALISE NV 13,756 0.0018
ARKK 6 Feb 2023 Buy TWST TWIST BIOSCIENCE CORP 49,263 0.0142
ARKK 6 Feb 2023 Buy RBLX ROBLOX CORP 130,100 0.0610
ARKK 2 Feb 2023 Sell MTLS MATERIALISE NV 22,248 0.0031
ARKK 1 Feb 2023 Sell MTLS MATERIALISE NV 28,894 0.0041
ARKK 30 Jan 2023 Buy TDOC TELADOC INC 239,920 0.0885
ARKK 30 Jan 2023 Buy NTLA INTELLIA THERAPEUTICS INC 5,989 0.0031
ARKK 30 Jan 2023 Sell MTLS MATERIALISE NV 16,739 0.0022
ARKK 27 Jan 2023 Sell MTLS MATERIALISE NV 126,153 0.0171
ARKK 27 Jan 2023 Sell EXAS EXACT SCIENCES CORP 156,704 0.1395
ARKK 26 Jan 2023 Buy TDOC TELADOC INC 99,464 0.0373
Latest Blogs
ARK by Cathie Wood is still suffering a year after its apex.

Cathie Wood's flagship exchange-traded fund hit an all-time high in February of this year. Her preferred disruptive-tech chasing strategy may still be in for a lot of suffering after a year and a 53 percent fall.

After a dramatic decline last month, the ARK Innovation ETF (ticker: ARKK) has steadied off - it's practically flat in February – but the headwinds surrounding its speculative growth picks are just becoming more vital. Many businesses that thrived during the pandemic are being hammered by the economic reopening, not only because yields are rising as investors prepare for the US Federal Reserve to raise interest rates, which is terrible news for unprofitable businesses, but also because the economic reopening is hammering many of the businesses that thrived during the pandemic.

Roku, Teladoc, and Zoom, all winners in the work-from-home era, have had their stock prices plummet by as much as 74% in the past year.

Short bets against ARK, according to IHS Markit data, hit a fresh high of 11.4 percent of outstanding shares this week. The Tuttle Capital Short Innovation ETF (SARK), which beats the ARK, now has assets worth more than $US300 million ($416 million).

"Those equities are supported by speculation, and speculation pays less well when the Fed raises rates," said Brent Schutte, chief investment strategist at Northwestern Mutual Wealth Management Co. "Much of what's happening in the market reminds me of what happened in the late 1990s when market segments were bid up to levels based on future assumptions."

Because its price chart resembles that of the Nasdaq index of technology businesses from more than two decades ago, analogies to that period and the dot-com implosion that followed are becoming more common in discussions of ARK.

"Today marks the 253rd trading day from ARK's all-time high," Jessica Rabe, co-founder of DataTrek Research, wrote in a Tuesday note, "while the Nasdaq was down 60% from its dot-com bubble top on the same day in 2001."

"If 2000/2001 analog holds, we should see ARK continuing to fall over the following three weeks. The Nasdaq dropped 18.7% in the next 16 trading days "recent."

Net flows are positive.

The better news for investors and Ms. Wood is that there may be some immediate respite. The Nasdaq rose 41% in six weeks in 2001 before falling.

The ARK Investment Management did not respond to a request for comment.

Most of ARK's $US15 billion asset loss has been attributed to bad performance, a plus for the company. Since the fund achieved an intraday high of $US159.70 a year ago this week, investors have withdrawn only around $US465 million, and ARK's net flows this year are positive despite a more than 20% drop.

This exceptional loyalty prevents a worsening situation and allows Wood's approach to recovering. The star fund manager has consistently emphasized that her funds have a five-year investment horizon and that she believes in many good options.

Mr. Schutte, on the other hand, says the drop is understandable because several of the company's biggest bets, such as Teladoc and Zoom, are becoming less significant as COVID-19 approaches.

"During the pandemic, there were a lot of questions about what would happen to society and how we'd go about our lives," he added.

"You drew in new investors who wanted to know "what are the upcoming themes I should invest in?" I believe you got a washout of it as well."

On Friday, Cathie Wood sold $148.9 million worth of Palantir stock, halving her exposure.

Ark Investment Management, run by Cathie Wood, sold more Palantir Technologies Inc PLTR -6.39 percent shares on Friday, cutting its stake in the Peter Thiel-backed company.

According to Friday's closing price, the famous investment management firm sold 13.5 million shares of the big data company, valued at $148.9 million.

Palantir's stock fell 6.4 percent to $11.02 per share on Friday. The stock has lost 16% of its value in the last week.

Before Friday's trade, Ark Invest held 25.53 million shares in Palantir, suggesting that the famous stock picker had trimmed over 52 percent of its total keeping a day later.

After the business disclosed lower-than-expected fourth-quarter earnings before the market opened on Thursday, Ark Invest, located in St. Petersburg, California, dumped shares in Palantir for the second time.

The software firm, well-known for its work with government organizations, posted earnings of 2 cents per share, falling short of the analyst consensus of 4 cents. The company recorded quarterly revenues of $432.87 million, higher than the $417.69 million predicted by analysts.

Palantir's stock had been sold for 4.77 million shares by the investment firm the day before.

All six of Ark Invest's active exchange-traded funds own Palantir stock, including the flagship Ark Innovation ETF ARKK -4.88 percent.

Before the recent sell-off, Ark Invest had been stockpiling Palantir shares for months.

Cathie Wood appeared on television to defend her ARK funds' dismal performance. It didn't go quite as planned.

The Ark Innovation ETF (ARKK), Cathie Wood's flagship fund, is down 30% year to date and more volatile than almost any other fund on the market. On CNBC's Halftime Report, Wood jumped at the chance to defend the fund and its deflated price, which is currently $68.80, down from $155 a year ago.

"We've seen a significant decline," Wood said, adding, "We feel innovation is at bargain basement zone." Even though her ETF was underperforming, she emphasized that her companies were still "very inexpensive" and that the current fund loss was temporary. When the call's 40 free minutes were finished, Zoom gave her an extra 10 minutes to complete the interview.

Having Zoom check to see whether she was "running out of time?" Wood, who has been aggressively buying up shares in Zoom and other IT firms that have fallen from their pandemic highs, was unhappy. Zoom, like Wood's other significant tech holdings, Teladoc Health, Roku, and Roblox, is down 20% to 40% year to date as investors worry about rising interest and inflation rates.

However, a significant chunk of the interview was devoted to a personal assault on Cathie Wood, who was named the most excellent stock picker in 2020 by Bloomberg's then-Editor-in-Chief Matthew Winkler after correctly forecasting that Tesla will one day be valued at more than $1 trillion.

Wood bluntly ignored Tuttle Capital Management's Short Innovation ETF (SARK), which tracks the inverse performance of ARKK using swaps contracts for the sole purpose of betting against Cathie Wood's selections. "They're not conducting any research." She explained, "All they're doing is shorting innovation."

Of course, SARK is betting against Cathie Woods, not on innovation. "Well, we stand for invention," Wood responded. The SARK ETF has gained 55 percent since its debut, whereas the ARKK ETF has declined by 42 percent.

Tuttle Capital Management CEO Matthew Tuttle chimed in on the SARK ETF, calling it a "tool" for investors. According to SARK, "to convey a negative view of the market, innovative enterprises, the current rising rate environment, or a [specific] portfolio manager if they wish." "It's un-American not to have options in the marketplace," Tuttle told Insider on Thursday.

In any event, Wood is making progress. Her main concern currently is bearish calls on her ETF. "Our major concern is that our investors convert temporary losses into long-term losses," Wood continued.